
### [MONDO:0019602](http://purl.obolibrary.org/obo/MONDO_0019602)
**Label:** other inborn metabolic disease

**Subclasses:** [MONDO:0020504](http://purl.obolibrary.org/obo/MONDO_0020504) (genetic recurrent myoglobinuria), [MONDO:0009992](http://purl.obolibrary.org/obo/MONDO_0009992) (myoglobinuria, acute recurrent, autosomal recessive), [MONDO:0009113](http://purl.obolibrary.org/obo/MONDO_0009113) (hemolytic anemia due to diphosphoglycerate mutase deficiency), [MONDO:0008046](http://purl.obolibrary.org/obo/MONDO_0008046) (autosomal dominant myoglobinuria), [MONDO:0010791](http://purl.obolibrary.org/obo/MONDO_0010791) (myoglobinuria, recurrent), [MONDO:0014109](http://purl.obolibrary.org/obo/MONDO_0014109) (NGLY1-deficiency), [MONDO:0010555](http://purl.obolibrary.org/obo/MONDO_0010555) (X-linked chondrodysplasia punctata 1), [MONDO:0013539](http://purl.obolibrary.org/obo/MONDO_0013539) (hypotonia-failure to thrive-microcephaly syndrome), [MONDO:0013282](http://purl.obolibrary.org/obo/MONDO_0013282) (alpha 1-antitrypsin deficiency), 

**Mapped go classes:** [GO:0006487](http://purl.obolibrary.org/obo/GO_0006487) (protein N-linked glycosylation), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0045444](http://purl.obolibrary.org/obo/GO_0045444) (fat cell differentiation), [GO:0046538](http://purl.obolibrary.org/obo/GO_0046538) (2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity), [GO:0004464](http://purl.obolibrary.org/obo/GO_0004464) (leukotriene-C4 synthase activity), [GO:0006642](http://purl.obolibrary.org/obo/GO_0006642) (triglyceride mobilization), [GO:0042975](http://purl.obolibrary.org/obo/GO_0042975) (peroxisome proliferator activated receptor binding), [GO:0005789](http://purl.obolibrary.org/obo/GO_0005789) (endoplasmic reticulum membrane), [GO:0006516](http://purl.obolibrary.org/obo/GO_0006516) (glycoprotein catabolic process), [GO:0005667](http://purl.obolibrary.org/obo/GO_0005667) (transcription factor complex), [GO:0006517](http://purl.obolibrary.org/obo/GO_0006517) (protein deglycosylation), [GO:0006515](http://purl.obolibrary.org/obo/GO_0006515) (protein quality control for misfolded or incompletely synthesized proteins), [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity), [GO:0001701](http://purl.obolibrary.org/obo/GO_0001701) (in utero embryonic development), [GO:0043231](http://purl.obolibrary.org/obo/GO_0043231) (intracellular membrane-bounded organelle), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0004619](http://purl.obolibrary.org/obo/GO_0004619) (phosphoglycerate mutase activity), [GO:0034389](http://purl.obolibrary.org/obo/GO_0034389) (lipid particle organization), [GO:0016853](http://purl.obolibrary.org/obo/GO_0016853) (isomerase activity), [GO:0008195](http://purl.obolibrary.org/obo/GO_0008195) (phosphatidate phosphatase activity), [GO:0006094](http://purl.obolibrary.org/obo/GO_0006094) (gluconeogenesis), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0042826](http://purl.obolibrary.org/obo/GO_0042826) (histone deacetylase binding), [GO:0006691](http://purl.obolibrary.org/obo/GO_0006691) (leukotriene metabolic process), [GO:0008152](http://purl.obolibrary.org/obo/GO_0008152) (metabolic process), [GO:0006096](http://purl.obolibrary.org/obo/GO_0006096) (glycolytic process), [GO:0042144](http://purl.obolibrary.org/obo/GO_0042144) (vacuole fusion, non-autophagic), [GO:0000224](http://purl.obolibrary.org/obo/GO_0000224) (peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity), [GO:0043434](http://purl.obolibrary.org/obo/GO_0043434) (response to peptide hormone), [GO:0000266](http://purl.obolibrary.org/obo/GO_0000266) (mitochondrial fission), [GO:0005635](http://purl.obolibrary.org/obo/GO_0005635) (nuclear envelope), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0030414](http://purl.obolibrary.org/obo/GO_0030414) (peptidase inhibitor activity), [GO:0005758](http://purl.obolibrary.org/obo/GO_0005758) (mitochondrial intermembrane space), [GO:0004867](http://purl.obolibrary.org/obo/GO_0004867) (serine-type endopeptidase inhibitor activity), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0004866](http://purl.obolibrary.org/obo/GO_0004866) (endopeptidase inhibitor activity), [GO:0001085](http://purl.obolibrary.org/obo/GO_0001085) (RNA polymerase II transcription factor binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0019432](http://purl.obolibrary.org/obo/GO_0019432) (triglyceride biosynthetic process), [GO:0010466](http://purl.obolibrary.org/obo/GO_0010466) (negative regulation of peptidase activity), [GO:0034097](http://purl.obolibrary.org/obo/GO_0034097) (response to cytokine), [GO:0016868](http://purl.obolibrary.org/obo/GO_0016868) (intramolecular transferase activity, phosphotransferases), [GO:0031065](http://purl.obolibrary.org/obo/GO_0031065) (positive regulation of histone deacetylation), [GO:0004082](http://purl.obolibrary.org/obo/GO_0004082) (bisphosphoglycerate mutase activity), [GO:0008484](http://purl.obolibrary.org/obo/GO_0008484) (sulfuric ester hydrolase activity), [GO:0044212](http://purl.obolibrary.org/obo/GO_0044212) (transcription regulatory region DNA binding), [GO:0016829](http://purl.obolibrary.org/obo/GO_0016829) (lyase activity), [GO:0004364](http://purl.obolibrary.org/obo/GO_0004364) (glutathione transferase activity), [GO:0008289](http://purl.obolibrary.org/obo/GO_0008289) (lipid binding), [GO:0008047](http://purl.obolibrary.org/obo/GO_0008047) (enzyme activator activity), [GO:0002020](http://purl.obolibrary.org/obo/GO_0002020) (protease binding), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0005773](http://purl.obolibrary.org/obo/GO_0005773) (vacuole), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0032869](http://purl.obolibrary.org/obo/GO_0032869) (cellular response to insulin stimulus), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0043295](http://purl.obolibrary.org/obo/GO_0043295) (glutathione binding), [GO:0003824](http://purl.obolibrary.org/obo/GO_0003824) (catalytic activity), [GO:0097466](http://purl.obolibrary.org/obo/GO_0097466) (ubiquitin-dependent glycoprotein ERAD pathway), [GO:0016311](http://purl.obolibrary.org/obo/GO_0016311) (dephosphorylation), [GO:0031532](http://purl.obolibrary.org/obo/GO_0031532) (actin cytoskeleton reorganization), [GO:0009062](http://purl.obolibrary.org/obo/GO_0009062) (fatty acid catabolic process), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0008654](http://purl.obolibrary.org/obo/GO_0008654) (phospholipid biosynthetic process), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0048821](http://purl.obolibrary.org/obo/GO_0048821) (erythrocyte development), [GO:0045598](http://purl.obolibrary.org/obo/GO_0045598) (regulation of fat cell differentiation), [GO:0006276](http://purl.obolibrary.org/obo/GO_0006276) (plasmid maintenance), [GO:0005741](http://purl.obolibrary.org/obo/GO_0005741) (mitochondrial outer membrane), [GO:0043456](http://purl.obolibrary.org/obo/GO_0043456) (regulation of pentose-phosphate shunt), [GO:0006953](http://purl.obolibrary.org/obo/GO_0006953) (acute-phase response), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0005811](http://purl.obolibrary.org/obo/GO_0005811) (lipid droplet), [GO:0031965](http://purl.obolibrary.org/obo/GO_0031965) (nuclear membrane), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0004602](http://purl.obolibrary.org/obo/GO_0004602) (glutathione peroxidase activity), [GO:0019370](http://purl.obolibrary.org/obo/GO_0019370) (leukotriene biosynthetic process), [GO:0003713](http://purl.obolibrary.org/obo/GO_0003713) (transcription coactivator activity), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0031529](http://purl.obolibrary.org/obo/GO_0031529) (ruffle organization), [GO:0006629](http://purl.obolibrary.org/obo/GO_0006629) (lipid metabolic process), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0009060](http://purl.obolibrary.org/obo/GO_0009060) (aerobic respiration), [GO:0019898](http://purl.obolibrary.org/obo/GO_0019898) (extrinsic component of membrane), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), 

**Class expressions from DL-Learner:**

- Thing 53.32%
- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 51.85%
- [GO:0005758](http://purl.obolibrary.org/obo/GO_0005758) (mitochondrial intermembrane space) 51.85%
- [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space) 51.85%
- [GO:0031970](http://purl.obolibrary.org/obo/GO_0031970) (organelle envelope lumen) and [GO:0044444](http://purl.obolibrary.org/obo/GO_0044444) (cytoplasmic part) 51.85%
- [GO:0031970](http://purl.obolibrary.org/obo/GO_0031970) (organelle envelope lumen) and [GO:0044429](http://purl.obolibrary.org/obo/GO_0044429) (mitochondrial part) 51.85%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) 37.21%
- [GO:0031970](http://purl.obolibrary.org/obo/GO_0031970) (organelle envelope lumen) 37.21%
- [GO:0031982](http://purl.obolibrary.org/obo/GO_0031982) (vesicle) and [GO:0043230](http://purl.obolibrary.org/obo/GO_0043230) (extracellular organelle) 37.21%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0003807](http://purl.obolibrary.org/obo/GO_0003807) (obsolete plasma kallikrein activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.21%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0003806](http://purl.obolibrary.org/obo/GO_0003806) (obsolete coagulation factor XIIa activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.21%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0003805](http://purl.obolibrary.org/obo/GO_0003805) (obsolete coagulation factor XIa activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.21%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0003804](http://purl.obolibrary.org/obo/GO_0003804) (obsolete coagulation factor Xa activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.21%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0003803](http://purl.obolibrary.org/obo/GO_0003803) (obsolete coagulation factor IXa activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.21%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0003802](http://purl.obolibrary.org/obo/GO_0003802) (obsolete coagulation factor VIIa activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.21%


